FIELD: medicine.
SUBSTANCE: method involves photodynamic exposure on a Vero cell culture of HSV-1 and HSV-2 infected African green monkey's kidney, on samples containing HSV-1 and HSV-2 and on a virus progeny; if observing a decrease of virus titre from a reference by 2 and more of lg TCD50/0.1 ml in the cell culture, samples containing the viruses, and in the virus progeny, the anti-herpetic action is considered to be effective.
EFFECT: using declared method enables more accurate assessment in vitro of the efficacy of the photodynamic therapy to study the mechanisms of various PDT options for the purpose of the further prediction of the PDT efficacy in the herpes-infected patients.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR VIRAL INFECTION CONTROL | 2019 |
|
RU2749968C2 |
| PHARMACEUTICAL COMPOSITION FOR HERPES TREATMENT | 1998 |
|
RU2165264C2 |
| ANTIVIRAL AGENT BASED ON DRY EXTRACT OF FRUIT BODY OF XYLOTROPHIC BASIDIOMYCETES Bjerkandera adusta | 2015 |
|
RU2580296C1 |
| ANTIVIRAL AGENT BASED ON TOTAL AMOUNT OF FLAVONOIDS FROM Alchemilla vulgaris L | 2015 |
|
RU2580304C1 |
| AGENT FOR VIRUS DISEASES PREVENTION AND TREATMENT AND METHOD OF VIRUS DISEASES PREVENTION AND TREATMENT | 2007 |
|
RU2337703C1 |
| METHOD FOR PREVENTIVE TREATMENT OF CORONAVIRUS INFECTION | 2020 |
|
RU2777462C2 |
| 4,6-DI(3,12-DIAZA-6,9-DIAZONIADISPIRO[5,2,5,2]HEXADECAN-1-YL)-2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE HYDROCHLORIDE HEXAHYDARATE FOR TREATING HERPETIC INFECTION, PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION | 2014 |
|
RU2573977C9 |
| ANTIVIRAL AGENT BASED ON DRY EXTRACT OF FRUIT BODY OF BASIDIOMYCETE Coprinus comatus | 2015 |
|
RU2584751C1 |
| METHOD FOR PREPARATION OF VIRION HERPETIC VACCINE | 1991 |
|
RU2014084C1 |
| ANTIVIRAL ACTIVITY OF FULLERENE AQUEOUS SOLUTION | 2018 |
|
RU2694754C1 |
